Answer
It is unknown whether the human C1-esterase inhibitor in Cinryze passes into breast milk; infant risk cannot be excluded, so a decision about stopping breast-feeding or stopping or avoiding Cinryze must weigh breast-feeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Cinryze 500 IU powder and solvent for solution for injectionTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 19Document updated
Sources checked